Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia

INTRODUCTION: Australia’s National Cervical Screening Program (NCSP) currently recommends 2-year cytology in women aged 18–69 years. Following a review of the NCSP prompted by the implementation of human papillomavirus (HPV) vaccination, the programme will transition in 2017 to 5-year primary HPV sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Canfell, Karen, Saville, Marion, Caruana, Michael, Gebski, Val, Darlington-Brown, Jessica, Brotherton, Julia, Heley, Stella, Castle, Philip E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829592/
https://www.ncbi.nlm.nih.gov/pubmed/29374658
http://dx.doi.org/10.1136/bmjopen-2017-016700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829592/
https://www.ncbi.nlm.nih.gov/pubmed/29374658
http://dx.doi.org/10.1136/bmjopen-2017-016700

Ejemplares similares